247 related articles for article (PubMed ID: 12196114)
1. Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs).
Fischer JA; Muff R; Born W
Biochem Soc Trans; 2002 Aug; 30(4):455-60. PubMed ID: 12196114
[TBL] [Abstract][Full Text] [Related]
2. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
Kikumoto K; Katafuchi T; Minamino N
Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
[TBL] [Abstract][Full Text] [Related]
3. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
4. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Thota C; Gangula PR; Dong YL; Yallampalli C
Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
[TBL] [Abstract][Full Text] [Related]
5. Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: the contributions of novel receptor-activity-modifying proteins.
Born W; Fischer JA; Muff R
Recept Channels; 2002; 8(3-4):201-9. PubMed ID: 12529937
[TBL] [Abstract][Full Text] [Related]
6. Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure.
Cueille C; Pidoux E; de Vernejoul MC; Ventura-Clapier R; Garel JM
Biochem Biophys Res Commun; 2002 Jun; 294(2):340-6. PubMed ID: 12051717
[TBL] [Abstract][Full Text] [Related]
7. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor.
Fraser NJ; Wise A; Brown J; McLatchie LM; Main MJ; Foord SM
Mol Pharmacol; 1999 Jun; 55(6):1054-9. PubMed ID: 10347248
[TBL] [Abstract][Full Text] [Related]
8. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
Lee SM; Hay DL; Pioszak AA
J Biol Chem; 2016 Apr; 291(16):8686-700. PubMed ID: 26895962
[TBL] [Abstract][Full Text] [Related]
10. Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus.
Nikitenko LL; Brown NS; Smith DM; MacKenzie IZ; Bicknell R; Rees MC
Mol Hum Reprod; 2001 Jul; 7(7):655-64. PubMed ID: 11420389
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
12. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.
Hilairet S; Foord SM; Marshall FH; Bouvier M
J Biol Chem; 2001 Aug; 276(31):29575-81. PubMed ID: 11387328
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin and related peptides: receptors and accessory proteins.
Muff R; Born W; Fischer JA
Peptides; 2001 Nov; 22(11):1765-72. PubMed ID: 11754962
[TBL] [Abstract][Full Text] [Related]
14. Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1.
Bomberger JM; Spielman WS; Hall CS; Weinman EJ; Parameswaran N
J Biol Chem; 2005 Jun; 280(25):23926-35. PubMed ID: 15805108
[TBL] [Abstract][Full Text] [Related]
15. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling.
Kuwasako K; Shimekake Y; Masuda M; Nakahara K; Yoshida T; Kitaura M; Kitamura K; Eto T; Sakata T
J Biol Chem; 2000 Sep; 275(38):29602-9. PubMed ID: 10882736
[TBL] [Abstract][Full Text] [Related]
16. The myocardial response to adrenomedullin involves increased cAMP generation as well as augmented Akt phosphorylation.
Pan CS; Jin SJ; Cao CQ; Zhao J; Zhang J; Wang X; Tang CS; Qi YF
Peptides; 2007 Apr; 28(4):900-9. PubMed ID: 17306419
[TBL] [Abstract][Full Text] [Related]
17. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
[TBL] [Abstract][Full Text] [Related]
18. Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking.
Bomberger JM; Parameswaran N; Hall CS; Aiyar N; Spielman WS
J Biol Chem; 2005 Mar; 280(10):9297-307. PubMed ID: 15613468
[TBL] [Abstract][Full Text] [Related]
19. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling.
Kamitani S; Sakata T
Biochim Biophys Acta; 2001 May; 1539(1-2):131-9. PubMed ID: 11389975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
